首页 › 基金 › DEERFIELD MANAGEMENT COMPANY, L.P. › PBLS

DEERFIELD MANAGEMENT COMPANY, L.P. 对 PBLS 的持仓历史

PARABILIS MEDICINES INC · 医疗保健

DEERFIELD MANAGEMENT COMPANY, L.P. 在 Q2 2026 的 13F 申报中披露持有 PBLS(PARABILIS MEDICINES INC)1,880,704 股,市值约 US$51.5M,约占其申报组合的 0.65%,在其申报持仓中市值排名第 43 位。 DEERFIELD MANAGEMENT COMPANY, L.P. 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)1.88M 股
申报持仓市值$51.47M
组合权重0.65%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

DEERFIELD MANAGEMENT COMPANY, L.P. 对 PBLS 的持仓演变

DEERFIELD MANAGEMENT COMPANY, L.P. 于 Q2 2026 首次披露 PBLS 持仓:1,880,704 股(约 US$51.5M)。

逐季持仓明细

季度股数金额变化
Q2 2026 1.88M $51.47M 新进

关于 PBLS 与 13F 数据

PBLS(PARABILIS MEDICINES INC)属于医疗保健行业。我们追踪的基金中还有 89 只申报持有 PBLS,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$791.9M), ARCH Venture Management, LLC (US$175.5M), venBio Partners LLC (US$144.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PBLS 的基金

查看 PBLS 的全部基金持有人 →

常见问题

How long has DEERFIELD MANAGEMENT COMPANY, L.P. held PBLS?

DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed PBLS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in PBLS?

As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 1.88M shares of PBLS (PARABILIS MEDICINES INC), valued at $51.47M, representing 0.65% of its reported portfolio and ranking #43.

Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling PBLS?

In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. newly opened its position in PBLS.

Which other funds hold PBLS?

Other major institutional holders of PBLS include RA CAPITAL MANAGEMENT, L.P., ARCH Venture Management, LLC, venBio Partners LLC, among 89 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.